Quantinuum Inc. (NASDAQ:QNT – Get Free Report) Director Vimal Kapur acquired 13,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $60.00 per share, with a total value of $780,000.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at $780,000. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
Quantinuum Stock Performance
QNT opened at $58.40 on Tuesday. Quantinuum Inc. has a twelve month low of $51.15 and a twelve month high of $71.35.
Trending Headlines about Quantinuum
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Director Hal Barron made the largest purchase, buying 250,000 shares for $15.0 million, a sizable increase in his ownership that stands out as a strong insider confidence signal. SEC filing for Hal Barron purchase
- Positive Sentiment: Multiple other directors also bought shares at $60 each, including Joseph Jimenez, who purchased 66,665 shares, and Manish H. Bhatia, Kenneth D. Denman, and others, reinforcing the bullish insider signal. SEC filing for Joseph Jimenez purchase
- Positive Sentiment: CFO Nitesh Sharan also added to his stake, which can help reassure investors that leadership remains aligned with shareholders. SEC filing for Nitesh Sharan purchase
- Neutral Sentiment: One article also highlighted a bullish opinion piece, “Quantinuum: Buying Apollo Today,” but it appears to be commentary rather than a new fundamental development. Seeking Alpha article
Read More
- Five stocks we like better than Quantinuum
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
